Senior Director, Clinical Lead - Neurodegeneration
Johnson & Johnson
Cambridge, Massachusetts, United States of America
Base: $226,000 to $391,000 usd; bonus/equity: elig...
Alzheimer's disease expertise required
Late phase drug development focus
Cross-functional team leadership
The incumbent will serve as a Clinical Leader in Neurodegeneration with a specific focus on innovative late-phase drug development for Alzheimer's Disease projects
Job Summary
The incumbent will serve as a Clinical Leader in Neurodegeneration with a specific focus on innovative late-phase drug development for Alzheimer's Disease projects.
This role requires leading cross-functional teams to execute clinical strategies, manage regulatory filings, and present findings to health authorities like the FDA and CHMP.
Johnson & Johnson offers a competitive base salary ranging from $226,000 to $391,000 USD along with comprehensive benefits including medical, dental, vision, and long-term incentives.
Matching Summary
The incumbent will serve as a Clinical Leader in Neurodegeneration with a specific focus on innovative late-phase drug development for Alzheimer's Disease projects.
Salary
Base: $226,000 to $391,000 USD; Bonus/Equity: Eligible for long-term incentive program; Benefits: Medical, dental, vision, life insurance, 401(k), and paid time off
Skills & Requirements
Must-have
Alzheimer's disease expertise required
Late phase drug development focus
Cross-functional team leadership
Regulatory filing preparation
FDA and EMA interaction experience
Nice-to-have
Innovative clinical trial design interest
Strong stakeholder management skills
Opinion leader relationship building
Strategic change management ability
Global market perspective
Key Requirements
MD or equivalent degree required
Board certification in neurology or psychiatry
Minimum 10 years in CNS clinical research
Detailed understanding of Alzheimer's disease pathology
Experience interacting with global health authorities